MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-09-2026
Neogen Corporation Total Liabilities 2011-2026 | NEOG
Annual Total Liabilities Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.37 B | 1.4 B | 1.42 B | 106 M | 79.8 M | 72 M | 57.8 M | 57.8 M | 56.7 M | 47.6 M | 41.2 M | 39 M | 32.3 M | 32.5 M | 30.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.42 B | 30.7 M | 323 M |
Quarterly Total Liabilities Neogen Corporation
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.26 B | 1.26 B | 1.26 B | 1.37 B | 1.38 B | 1.39 B | 1.37 B | 1.4 B | 1.44 B | 1.45 B | 1.41 B | 1.42 B | 1.38 B | 1.46 B | 93.6 M | 106 M | 106 M | 101 M | 76.7 M | 79.8 M | 79.8 M | 68.2 M | 70 M | 72 M | 61.6 M | 59.7 M | 60.8 M | 57.8 M | 57.8 M | 58.4 M | 59.3 M | 57.8 M | 57.8 M | 60.4 M | 60.1 M | 56.7 M | 56.7 M | 52.5 M | 51.4 M | 45.8 M | 47.6 M | 47.9 M | 43.5 M | 41.2 M | 41.2 M | 39.1 M | 38.8 M | 39 M | 39 M | 37.9 M | 37.4 M | 32.3 M | 32.3 M | 32 M | 31.6 M | 32.5 M | 32.5 M | 31.2 M | 31.1 M | 30.7 M | 30.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.46 B | 30.7 M | 357 M |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.32 B | $ 116.36 | 0.7 % | $ 35.4 B |  USA |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
2.7 B | $ 128.32 | 0.34 % | $ 20.4 B | USA |
 |
Co-Diagnostics
CODX
|
4.11 M | $ 1.68 | 0.6 % | $ 2.23 M | USA |
 |
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 84.5 | 0.2 % | $ 5.7 B | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 25.0 | 2.19 % | $ 694 M | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 415.6 | 1.23 % | $ 12 B | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M |  Israel |
 |
Koninklijke Philips N.V.
PHG
|
16 B | $ 27.65 | 0.66 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
110 M | $ 21.56 | 1.53 % | $ 1.15 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
Senseonics Holdings
SENS
|
65.2 M | $ 7.03 | -0.28 % | $ 293 M | USA |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Soleno Therapeutics
SLNO
|
114 M | $ 52.75 | 0.05 % | $ 2.68 B | USA |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 16.26 | -0.31 % | $ 492 M | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Thermo Fisher Scientific
TMO
|
28.7 B | $ 470.43 | 0.18 % | $ 177 B | USA |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
Trinity Biotech plc
TRIB
|
138 M | $ 0.65 | -0.62 % | $ 61.9 M |  Irlanda |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 173.04 | 1.91 % | $ 8.58 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
169 M | $ 60.29 | -1.07 % | $ 3.61 B | USA |
 |
Guardant Health
GH
|
2.11 B | $ 89.18 | 0.3 % | $ 11.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
11.5 M | $ 1.98 | - | $ 8.76 M | USA |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
1.84 M | $ 2.17 | 1.4 % | $ 4.98 M | USA |
 |
National Research Corporation
NRC
|
121 M | $ 17.46 | 1.33 % | $ 391 M | USA |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 101.74 | -0.43 % | $ 8.39 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 264.08 | 0.11 % | $ 22 B | USA |
 |
Celcuity
CELC
|
366 M | $ 126.32 | 4.37 % | $ 5.91 B | USA |
 |
OpGen
OPGN
|
2.48 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
523 M | $ 8.35 | 0.72 % | $ 1.07 B | USA |
 |
Myriad Genetics
MYGN
|
339 M | $ 4.86 | 1.57 % | $ 450 M | USA |
 |
Natera
NTRA
|
689 M | $ 205.24 | 0.73 % | $ 20.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 196.28 | 0.04 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
1.85 B | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
4.92 B | - | -0.91 % | $ 14.7 B | USA |